The global vascular imaging market is expected to reach USD 5.95 billion by 2022, at a CAGR of 6.5 percent from 2017 to 2022, states Reports and Reports. The major factors driving this market are the rising incidence and prevalence of cardiovascular disease (CVDs), growing aging population, and technological innovations in vascular imaging systems. On the other hand, the growth of this market is restrained to some extent due to the accessibility of conventional low-cost alternates to treat CVDs.
The MRI segment is expected to register the highest growth during 2017–2022. This is attributed to the increasing incidence of CVDs and the launch of advanced MRI systems. End-user hospital segment is estimated to register the highest growth. This can be attributed to technological development, increasing healthcare expenditure, and increasing use of imaging systems in hospitals and hybrid operating rooms.
Geographically, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World. The Asian market is estimated to register the highest growth, which can be attributed to the increasing expenditure in healthcare, growing penetration of health insurance, and rise in disposable incomes especially in countries like China, Japan, and India.